4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000013
President and CEO gave up 3,324 shares (to pay taxes)
- President and CEO acquired 99,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2023-03-01 | Grant or award | +99,300 | 261,135 | D: show line 1 in the form | ||
| Doshi Dipal President and CEO | 2023-03-02 | Shares withheld for taxes | −3,324 | $11.60 | $38,546 | 257,811 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +150,500 | 150,500 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_167787923707368.xml…